Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III efficacy study of cell-derived and egg-derived subunit influenza vaccines versus placebo in healthy adults
2007-002871-15Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2007
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of influenza vaccine surface antigen inactivated prepared in cell cultures and egg-derived influenza subunit vaccine in influenza (3 arms), sponsored by Novartis. Primary endpoint: Measures of efficacy. Started Jul 2007; status: completed.
02
Drugs
influenza vaccine surface antigen inactivated prepared in cell culturesegg-derived influenza subunit vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-002871-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002871-15.